{"doi":"10.1016/j.vaccine.2010.09.021","title":"Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009–January 31, 2010","abstract":null,"journal":"Vaccine","year":2010,"id":27695,"datarank":7.7768750681710594,"base_score":4.812184355372417,"endowment":4.812184355372417,"self_citation_contribution":0.7218276533058626,"citation_network_contribution":7.0550474148651965,"self_endowment_contribution":0.7218276533058626,"citer_contribution":7.0550474148651965,"corpus_percentile":null,"corpus_rank":null,"citation_count":122,"citer_count":83,"citers_with_citation_signal":77,"citers_with_endowment":77,"datacite_reuse_total":2,"is_dataset":false,"is_dataset_confidence":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":157121,"name":"Karen R. Broder","orcid":null,"position":1,"is_corresponding":false},{"id":157122,"name":"Penina Haber","orcid":null,"position":2,"is_corresponding":false},{"id":157123,"name":"Alice Guh","orcid":null,"position":3,"is_corresponding":false},{"id":157124,"name":"Michael Nguyen","orcid":null,"position":4,"is_corresponding":false},{"id":157125,"name":"Maria Cano","orcid":null,"position":5,"is_corresponding":false},{"id":157126,"name":"Paige Lewis","orcid":null,"position":6,"is_corresponding":false},{"id":157127,"name":"Michael M. McNeil","orcid":null,"position":7,"is_corresponding":false},{"id":157128,"name":"Marthe Bryant","orcid":null,"position":8,"is_corresponding":false},{"id":157129,"name":"James Singleton","orcid":null,"position":9,"is_corresponding":false},{"id":44599,"name":"David Martin","orcid":null,"position":10,"is_corresponding":false},{"id":157130,"name":"Frank DeStefano","orcid":null,"position":11,"is_corresponding":false},{"id":157120,"name":"Claudia Vellozzi","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":4.812184355372417,"endowment":4.812184355372417,"datacite_reuse_total":2,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"20850534","pmcid":null,"openalex_id":"https://openalex.org/W1967736925","authors":[],"funders":[],"total_grants":0,"fwci":10.3862,"citation_percentile":0.99064126,"influential_citations":2,"citation_trend":[{"year":2012,"count":24},{"year":2013,"count":17},{"year":2014,"count":10},{"year":2015,"count":15},{"year":2016,"count":4},{"year":2017,"count":7},{"year":2018,"count":3},{"year":2019,"count":3},{"year":2020,"count":1},{"year":2021,"count":1},{"year":2022,"count":4},{"year":2023,"count":2},{"year":2024,"count":2},{"year":2025,"count":2}],"oa_status":"closed","license":"https://www.elsevier.com/tdm/userlicense/1.0/","oa_locations":[{"url":"https://api.elsevier.com/content/article/PII:S0264410X10013319?httpAccept=text/xml","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S0264410X10013319?httpAccept=text/plain","host_type":"publisher"},{"url":"https://doi.org/10.1016/j.vaccine.2010.09.021","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/20850534","host_type":"repository"}],"fields_of_study":["SARS-CoV-2 and COVID-19 Research","Pharmacovigilance and Adverse Drug Reactions","Influenza Virus Research Studies","Medicine","Adolescent","Adult","Adverse Drug Reaction Reporting Systems","Aged","Child","Child, Preschool","Data Mining","Female","Humans","Infant","Influenza A Virus, H1N1 Subtype","Influenza Vaccines","Influenza, Human","Male","Middle Aged","Product Surveillance, Postmarketing","United States","Vaccination","Young Adult"],"mesh_terms":["Adolescent","Adult","Aged","Child","Child, Preschool","Female","Humans","Infant","Influenza, Human","Influenza Vaccines","Male","Middle Aged","Product Surveillance, Postmarketing","United States","Vaccination","Adverse Drug Reaction Reporting Systems","Influenza A Virus, H1N1 Subtype","Young Adult","Data Mining"],"keywords":["Adverse Event Reporting System","Adverse effect","Medicine","Vaccination","Influenza vaccine","Pharmacovigilance","Pediatrics","Virology","Internal medicine"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[{"doi":"10.6084/m9.figshare.20455000.v1","title":"Additional file 1 of Enhanced passive safety surveillance of a quadrivalent inactivated split virion influenza vaccine in Finland during the influenza season 2020/21","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.20455000","title":"Additional file 1 of Enhanced passive safety surveillance of a quadrivalent inactivated split virion influenza vaccine in Finland during the influenza season 2020/21","publisher":"figshare","resource_type":"JournalArticle"}],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-08T19:08:23.264389Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}